When α4-1BB is combined with AlloDCs, the treatment altered the immunosuppressive microenvironment with enhanced infiltration of matured and antigen-presenting tumor-infiltrating DCs and reduced number of MDSC and Tregs, which supports the effectiveness of cytotoxic CD8 T-cells. Here, CD8A is linked to neoplasm.